|
MPZL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.80130355076358E-11 |
| Normal-vs-Stage2 |
2.04159999999121E-05 |
| Normal-vs-Stage3 |
4.06040000000552E-05 |
| Normal-vs-Stage4 |
1.232360E-02 |
| Stage1-vs-Stage2 |
3.033800E-01 |
| Stage1-vs-Stage3 |
5.587900E-02 |
| Stage1-vs-Stage4 |
2.096000E-01 |
| Stage2-vs-Stage3 |
2.810800E-01 |
| Stage2-vs-Stage4 |
4.144400E-01 |
| Stage3-vs-Stage4 |
9.165400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.99200722162641E-16 |
| Normal-vs-AfricanAmerican |
2.06979999806123E-09 |
| Normal-vs-Asian |
1.055830E-01 |
| Caucasian-vs-AfricanAmerican |
9.285600E-01 |
| Caucasian-vs-Asian |
4.750400E-01 |
| AfricanAmerican-vs-Asian |
4.521400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63302704692114E-12 |
| Normal-vs-Female |
5.10991249313975E-12 |
| Male-vs-Female |
2.807500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.40729999997813E-06 |
| Normal-vs-Extreme_Weight |
2.96830005019899E-10 |
| Normal-vs-Obese |
7.68729968569914E-10 |
| Normal-vs-Extreme_Obese |
8.544100E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.275800E-01 |
| Normal_Weight-vs-Obese |
1.478810E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.643800E-01 |
| Extreme_Weight-vs-Obese |
6.599500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.138800E-01 |
| Obese-vs-Extreme_Obese |
3.538600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.400700E-04 |
| Normal-vs-Age(41-60Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(61-80Yrs) |
5.2590154453469E-12 |
| Normal-vs-Age(81-100Yrs) |
5.344500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.740300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.512400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.703500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.142000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.006400E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.936240E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.246300E-04 |
| Normal-VS-KIRP CIMP |
5.551900E-04 |
| Normal-VS-Unclassified PRCC |
3.76380000499665E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.876690E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.572460E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.220200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.52540000003732E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
5.017700E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
3.084300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.03969999998288E-06 |
| Normal-vs-N1 |
4.07180000000507E-05 |
| Normal-vs-N2 |
2.630000E-02 |
| N0-vs-N1 |
4.142600E-03 |
| N0-vs-N2 |
4.947700E-02 |
| N1-vs-N2 |
2.010800E-01 |
|
|
